Categories: News

Edison Issues Report on Baillie Gifford China Growth Trust (BGCG)

London, United Kingdom–(Newsfile Corp. – July 22, 2024) – Edison issues report on Baillie Gifford China Growth Trust (LSE: BGCG). 

Baillie Gifford China Growth Trust’s investment objective is to produce long-term capital growth by investing predominantly in shares of Chinese companies. Performance is measured against the MSCI China All Shares Index. Baillie Gifford took over management of the trust from Witan Investment Services on 16 September 2020. Previously the trust aimed for capital and income growth from a diversified portfolio of investments in the Asia-Pacific region.

Click here to read the full report.

All reports published by Edison are available to download free of charge from its website www.edisongroup.com

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:
enquiries@edisongroup.com
+44 (0)20 3077 5700

Connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/
X www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217289

Staff

Recent Posts

Pusan National University Researchers Revolutionize Environmental Health with Advanced Explainable Machine Learning Approach

Machine Learning with FLIT-SHAP Reveals Crucial Pollutant Interactions, Enhancing Toxicity Predictions and Environmental Health Decision-Making…

33 mins ago

Elucid Names Kelly Huang as CEO

Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship…

3 hours ago

NervGen Pharma Appoints Neil Klompas to Board of Directors

Seasoned pharmaceutical executive with extensive experience in high-growth life sciences companies joins NervGenLeadership appointment supports…

3 hours ago

Omni-Biotic AB 10 Wins Product of the Year at NutraIngredients USA Awards 2024

NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Omni-Biotic US is proud to…

3 hours ago

Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024

NEWARK, CA / ACCESSWIRE / July 22, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or…

3 hours ago